April 2016 - Volume 45 - Issue 4 - Contributor Index

Alphabetical Search
I
Author:
Author:
Andersen, Clark

FIVE-YEAR OUTCOMES AFTER LONG-TERM OXANDROLONE ADMINISTRATION IN SEVERELY BURNED CHILDREN: A RANDOMIZED CLINICAL TRIAL

Reeves, Patrick T.; Herndon, David N.; Tanksley, Jessica D.; More

Shock. 45(4):367-374, April 2016.

A PPARγ AGONIST ENHANCES BACTERIAL CLEARANCE THROUGH NEUTROPHIL EXTRACELLULAR TRAP FORMATION AND IMPROVES SURVIVAL IN SEPSIS

Araújo, Cláudia V.; Campbell, Clarissa; Gonçalves-de-Albuquerque, Cassiano F.; More

Shock. 45(4):393-403, April 2016.

Author:
Bayrakci, Benan

EFFECT OF GTS-21, AN ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR AGONIST, ON CLP-INDUCED INFLAMMATORY, GASTROINTESTINAL MOTILITY, AND COLONIC PERMEABILITY CHANGES IN MICE

Nullens, Sara; Staessens, Michael; Peleman, Cédric; More

Shock. 45(4):450-459, April 2016.

A PPARγ AGONIST ENHANCES BACTERIAL CLEARANCE THROUGH NEUTROPHIL EXTRACELLULAR TRAP FORMATION AND IMPROVES SURVIVAL IN SEPSIS

Araújo, Cláudia V.; Campbell, Clarissa; Gonçalves-de-Albuquerque, Cassiano F.; More

Shock. 45(4):393-403, April 2016.

Author:
Cahoon, Jena

A PPARγ AGONIST ENHANCES BACTERIAL CLEARANCE THROUGH NEUTROPHIL EXTRACELLULAR TRAP FORMATION AND IMPROVES SURVIVAL IN SEPSIS

Araújo, Cláudia V.; Campbell, Clarissa; Gonçalves-de-Albuquerque, Cassiano F.; More

Shock. 45(4):393-403, April 2016.

A PPARγ AGONIST ENHANCES BACTERIAL CLEARANCE THROUGH NEUTROPHIL EXTRACELLULAR TRAP FORMATION AND IMPROVES SURVIVAL IN SEPSIS

Araújo, Cláudia V.; Campbell, Clarissa; Gonçalves-de-Albuquerque, Cassiano F.; More

Shock. 45(4):393-403, April 2016.

PHARMACOLOGICAL SIRT1 ACTIVATION IMPROVES MORTALITY AND MARKEDLY ALTERS TRANSCRIPTIONAL PROFILES THAT ACCOMPANY EXPERIMENTAL SEPSIS

Opal, Steven M.; Ellis, James L.; Suri, Vipin; More

Shock. 45(4):411-418, April 2016.

PHARMACOLOGICAL SIRT1 ACTIVATION IMPROVES MORTALITY AND MARKEDLY ALTERS TRANSCRIPTIONAL PROFILES THAT ACCOMPANY EXPERIMENTAL SEPSIS

Opal, Steven M.; Ellis, James L.; Suri, Vipin; More

Shock. 45(4):411-418, April 2016.

Author:
Chen, Dong-Ling

FIVE-YEAR OUTCOMES AFTER LONG-TERM OXANDROLONE ADMINISTRATION IN SEVERELY BURNED CHILDREN: A RANDOMIZED CLINICAL TRIAL

Reeves, Patrick T.; Herndon, David N.; Tanksley, Jessica D.; More

Shock. 45(4):367-374, April 2016.

Author:
Cody, Mark J.

A PPARγ AGONIST ENHANCES BACTERIAL CLEARANCE THROUGH NEUTROPHIL EXTRACELLULAR TRAP FORMATION AND IMPROVES SURVIVAL IN SEPSIS

Araújo, Cláudia V.; Campbell, Clarissa; Gonçalves-de-Albuquerque, Cassiano F.; More

Shock. 45(4):393-403, April 2016.

Author:
Coppa, Gene F.

FIVE-YEAR OUTCOMES AFTER LONG-TERM OXANDROLONE ADMINISTRATION IN SEVERELY BURNED CHILDREN: A RANDOMIZED CLINICAL TRIAL

Reeves, Patrick T.; Herndon, David N.; Tanksley, Jessica D.; More

Shock. 45(4):367-374, April 2016.

EFFECT OF GTS-21, AN ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR AGONIST, ON CLP-INDUCED INFLAMMATORY, GASTROINTESTINAL MOTILITY, AND COLONIC PERMEABILITY CHANGES IN MICE

Nullens, Sara; Staessens, Michael; Peleman, Cédric; More

Shock. 45(4):450-459, April 2016.

EFFECT OF GTS-21, AN ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR AGONIST, ON CLP-INDUCED INFLAMMATORY, GASTROINTESTINAL MOTILITY, AND COLONIC PERMEABILITY CHANGES IN MICE

Nullens, Sara; Staessens, Michael; Peleman, Cédric; More

Shock. 45(4):450-459, April 2016.

Author:
Dull, Randal O.
Author:
Ellis, James L.

PHARMACOLOGICAL SIRT1 ACTIVATION IMPROVES MORTALITY AND MARKEDLY ALTERS TRANSCRIPTIONAL PROFILES THAT ACCOMPANY EXPERIMENTAL SEPSIS

Opal, Steven M.; Ellis, James L.; Suri, Vipin; More

Shock. 45(4):411-418, April 2016.

Author:
Elmér, Eskil

FIVE-YEAR OUTCOMES AFTER LONG-TERM OXANDROLONE ADMINISTRATION IN SEVERELY BURNED CHILDREN: A RANDOMIZED CLINICAL TRIAL

Reeves, Patrick T.; Herndon, David N.; Tanksley, Jessica D.; More

Shock. 45(4):367-374, April 2016.

Author:
Francque, Sven

EFFECT OF GTS-21, AN ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR AGONIST, ON CLP-INDUCED INFLAMMATORY, GASTROINTESTINAL MOTILITY, AND COLONIC PERMEABILITY CHANGES IN MICE

Nullens, Sara; Staessens, Michael; Peleman, Cédric; More

Shock. 45(4):450-459, April 2016.

PHARMACOLOGICAL SIRT1 ACTIVATION IMPROVES MORTALITY AND MARKEDLY ALTERS TRANSCRIPTIONAL PROFILES THAT ACCOMPANY EXPERIMENTAL SEPSIS

Opal, Steven M.; Ellis, James L.; Suri, Vipin; More

Shock. 45(4):411-418, April 2016.

Author:
Ge, Lin
Author:
Golub, Lorne M.

A PPARγ AGONIST ENHANCES BACTERIAL CLEARANCE THROUGH NEUTROPHIL EXTRACELLULAR TRAP FORMATION AND IMPROVES SURVIVAL IN SEPSIS

Araújo, Cláudia V.; Campbell, Clarissa; Gonçalves-de-Albuquerque, Cassiano F.; More

Shock. 45(4):393-403, April 2016.

Author:
Hara, Naomi
Author:
Hays, Joshua P.

FIVE-YEAR OUTCOMES AFTER LONG-TERM OXANDROLONE ADMINISTRATION IN SEVERELY BURNED CHILDREN: A RANDOMIZED CLINICAL TRIAL

Reeves, Patrick T.; Herndon, David N.; Tanksley, Jessica D.; More

Shock. 45(4):367-374, April 2016.

Author:
He, Xiang-Hu

FIVE-YEAR OUTCOMES AFTER LONG-TERM OXANDROLONE ADMINISTRATION IN SEVERELY BURNED CHILDREN: A RANDOMIZED CLINICAL TRIAL

Reeves, Patrick T.; Herndon, David N.; Tanksley, Jessica D.; More

Shock. 45(4):367-374, April 2016.

Author:
Ho, Low-Tone
Author:
Hong, Yucai
Author:
Hosokawa, Koji
Author:
Jain, Sumeet

FIVE-YEAR OUTCOMES AFTER LONG-TERM OXANDROLONE ADMINISTRATION IN SEVERELY BURNED CHILDREN: A RANDOMIZED CLINICAL TRIAL

Reeves, Patrick T.; Herndon, David N.; Tanksley, Jessica D.; More

Shock. 45(4):367-374, April 2016.

Author:
Jian, Deng-Yuan
Author:
Jiang, Lin-Lin
Author:
Juan, Chi-Chang

PHARMACOLOGICAL SIRT1 ACTIVATION IMPROVES MORTALITY AND MARKEDLY ALTERS TRANSCRIPTIONAL PROFILES THAT ACCOMPANY EXPERIMENTAL SEPSIS

Opal, Steven M.; Ellis, James L.; Suri, Vipin; More

Shock. 45(4):411-418, April 2016.

Author:
Khader, Adam
Author:
Kilbaugh, Todd

FIVE-YEAR OUTCOMES AFTER LONG-TERM OXANDROLONE ADMINISTRATION IN SEVERELY BURNED CHILDREN: A RANDOMIZED CLINICAL TRIAL

Reeves, Patrick T.; Herndon, David N.; Tanksley, Jessica D.; More

Shock. 45(4):367-374, April 2016.

Author:
Kwok, Ching-Fai
Author:
Lee, Jong O.

FIVE-YEAR OUTCOMES AFTER LONG-TERM OXANDROLONE ADMINISTRATION IN SEVERELY BURNED CHILDREN: A RANDOMIZED CLINICAL TRIAL

Reeves, Patrick T.; Herndon, David N.; Tanksley, Jessica D.; More

Shock. 45(4):367-374, April 2016.

Author:
Li, Yong

PHARMACOLOGICAL SIRT1 ACTIVATION IMPROVES MORTALITY AND MARKEDLY ALTERS TRANSCRIPTIONAL PROFILES THAT ACCOMPANY EXPERIMENTAL SEPSIS

Opal, Steven M.; Ellis, James L.; Suri, Vipin; More

Shock. 45(4):411-418, April 2016.

Author:
Lin, Yu-Ting
Author:
Liu, Zhiyong

EFFECT OF GTS-21, AN ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR AGONIST, ON CLP-INDUCED INFLAMMATORY, GASTROINTESTINAL MOTILITY, AND COLONIC PERMEABILITY CHANGES IN MICE

Nullens, Sara; Staessens, Michael; Peleman, Cédric; More

Shock. 45(4):450-459, April 2016.

EFFECT OF GTS-21, AN ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR AGONIST, ON CLP-INDUCED INFLAMMATORY, GASTROINTESTINAL MOTILITY, AND COLONIC PERMEABILITY CHANGES IN MICE

Nullens, Sara; Staessens, Michael; Peleman, Cédric; More

Shock. 45(4):450-459, April 2016.

Author:
Meyer, Walter

FIVE-YEAR OUTCOMES AFTER LONG-TERM OXANDROLONE ADMINISTRATION IN SEVERELY BURNED CHILDREN: A RANDOMIZED CLINICAL TRIAL

Reeves, Patrick T.; Herndon, David N.; Tanksley, Jessica D.; More

Shock. 45(4):367-374, April 2016.

FIVE-YEAR OUTCOMES AFTER LONG-TERM OXANDROLONE ADMINISTRATION IN SEVERELY BURNED CHILDREN: A RANDOMIZED CLINICAL TRIAL

Reeves, Patrick T.; Herndon, David N.; Tanksley, Jessica D.; More

Shock. 45(4):367-374, April 2016.

A PPARγ AGONIST ENHANCES BACTERIAL CLEARANCE THROUGH NEUTROPHIL EXTRACELLULAR TRAP FORMATION AND IMPROVES SURVIVAL IN SEPSIS

Araújo, Cláudia V.; Campbell, Clarissa; Gonçalves-de-Albuquerque, Cassiano F.; More

Shock. 45(4):393-403, April 2016.

Author:
Morata, Saori
Author:
Nieman, Gary
Author:
Nullens, Sara

EFFECT OF GTS-21, AN ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR AGONIST, ON CLP-INDUCED INFLAMMATORY, GASTROINTESTINAL MOTILITY, AND COLONIC PERMEABILITY CHANGES IN MICE

Nullens, Sara; Staessens, Michael; Peleman, Cédric; More

Shock. 45(4):450-459, April 2016.

Author:
Opal, Steven M.

PHARMACOLOGICAL SIRT1 ACTIVATION IMPROVES MORTALITY AND MARKEDLY ALTERS TRANSCRIPTIONAL PROFILES THAT ACCOMPANY EXPERIMENTAL SEPSIS

Opal, Steven M.; Ellis, James L.; Suri, Vipin; More

Shock. 45(4):411-418, April 2016.

PHARMACOLOGICAL SIRT1 ACTIVATION IMPROVES MORTALITY AND MARKEDLY ALTERS TRANSCRIPTIONAL PROFILES THAT ACCOMPANY EXPERIMENTAL SEPSIS

Opal, Steven M.; Ellis, James L.; Suri, Vipin; More

Shock. 45(4):411-418, April 2016.

PHARMACOLOGICAL SIRT1 ACTIVATION IMPROVES MORTALITY AND MARKEDLY ALTERS TRANSCRIPTIONAL PROFILES THAT ACCOMPANY EXPERIMENTAL SEPSIS

Opal, Steven M.; Ellis, James L.; Suri, Vipin; More

Shock. 45(4):411-418, April 2016.

EFFECT OF GTS-21, AN ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR AGONIST, ON CLP-INDUCED INFLAMMATORY, GASTROINTESTINAL MOTILITY, AND COLONIC PERMEABILITY CHANGES IN MICE

Nullens, Sara; Staessens, Michael; Peleman, Cédric; More

Shock. 45(4):450-459, April 2016.

Author:
Prince, Jose M.
Author:
Qian, Jie

FIVE-YEAR OUTCOMES AFTER LONG-TERM OXANDROLONE ADMINISTRATION IN SEVERELY BURNED CHILDREN: A RANDOMIZED CLINICAL TRIAL

Reeves, Patrick T.; Herndon, David N.; Tanksley, Jessica D.; More

Shock. 45(4):367-374, April 2016.